Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab - the FAB-HCC pilot study. - Pomej K; Frick A; Scheiner B; Balcar L; Pajancic L; Klotz A; Kreuter A; Lampichler K; Regnat K; Zinober K; Trauner M; Tamandl D; et al. (PloS one, 2025)